ArticleFrontiers in oncology2022

Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.

Alessandro Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.